Literature DB >> 27265603

Cardiac Lymphoma.

Jean Jeudy1, Allen P Burke2, Aletta Ann Frazier3.   

Abstract

Lymphoma of the heart and pericardium may develop in up to 25% of patients with disseminated nodal disease, but primary cardiac lymphoma is rare. The majority are diffuse large B-cell lymphomas, which arise in immunocompetent older individuals, men twice as often as women. Subsets are found in immunocompromised patients, including those with HIV-AIDS or allograft recipients. Cardiac lymphomas tend to arise in the wall of the right heart, especially right atrium, with contiguous infiltration of epicardium and pericardium. Pericardial implants and effusions are common. The disease is often multifocal in the heart, but cardiac valves are usually spared.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac neoplasia; Diffuse large B-cell lymphoma; Posttransplant lymphoproliferative disorder (PTLD); Primary cardiac lymphoma; Primary effusion lymphoma

Mesh:

Year:  2016        PMID: 27265603     DOI: 10.1016/j.rcl.2016.03.006

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  18 in total

Review 1.  Cardiac lymphoma with early response to chemotherapy: A case report and review of the literature.

Authors:  Andrea Bonelli; Sara Paris; Stefano Bisegna; Giuseppe Milesi; Emanuele Gavazzi; Raffaele Giubbini; Chiara Cattaneo; Fabio Facchetti; Pompilio Faggiano
Journal:  J Nucl Cardiol       Date:  2021-03-11       Impact factor: 5.952

2.  Primary cardiac lymphoma in HIV infected patients: A clinicopathological report of two cases.

Authors:  Moshawa Calvin Khaba; Makenga Fidele Kampetu; Mamokgethi Christina Rangaka; Mohamed Karodia; Shere Peter Ramoroko; Elelwani Innocentia Madzhia
Journal:  Ann Med Surg (Lond)       Date:  2021-08-23

Review 3.  A Clinico-Pathologic Approach to the Differential Diagnosis of Pericardial Tumors.

Authors:  Alison R Krywanczyk; Carmela D Tan; E Rene Rodriguez
Journal:  Curr Cardiol Rep       Date:  2021-07-16       Impact factor: 2.931

4.  Case Report: Cardiac Involvement by Lymphoma: Rare but Heterogeneous Condition With Challenging Behaviors.

Authors:  Elisa Lucchini; Marco Merlo; Mario Ballerini; Aldostefano Porcari; Gianfranco Sinagra; Lorenzo Pagnan; Marco Rensi; Andrea Romano; Rossana Bussani; Laura Ballotta; Francesco Zaja
Journal:  Front Oncol       Date:  2021-04-27       Impact factor: 6.244

5.  An Intracardiac Pathology Mimicking Cardiac Tamponade.

Authors:  Harsh Kumar Pandey; Arun Gopalakrishnan; A N Deepti; Shivang Saxena; Bineesh K Radhakrishnan
Journal:  Acta Cardiol Sin       Date:  2022-01       Impact factor: 2.672

6.  A case of complete atrioventricular block associated with primary cardiac lymphoma reversed without cardiac pacemaker implantation.

Authors:  Bowen Hu; Jian Zhao; Xin Liang; Changzhen Ren; Na Li; Chun Liang
Journal:  J Int Med Res       Date:  2022-04       Impact factor: 1.671

7.  [A clinical analysis of 10 cases with cardiac lymphoma].

Authors:  Y H Li; C Y Shi; F Q Duan; Y Pang; H B Li; L Q Zhang; Z H Liu; L Ouyang; C Y Yue; M C Xie; Z J Jiang; Y Xiao
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-02-14

8.  Tachy- and bradyarrhythmia as an initial presentation of human immunodeficiency virus-related primary cardiac lymphoma: a case report.

Authors:  Shonda Ng; Cindy Krisnadi; Randal Jun Bang Low; Min Sen Yew
Journal:  Eur Heart J Case Rep       Date:  2019-12-04

9.  Syncope and Cardiac Tamponade: Multimodality Imaging of Primary Cardiac Lymphoma.

Authors:  Virginia Serra; Francesco De Luca; Ketty Savino; Maurizio Del Pinto; Claudia Castellani; Paola Fiaschini; Laura Tomasello; Claudio Cavallini
Journal:  J Cardiovasc Echogr       Date:  2021-05-21

10.  Cardiac involvement in disseminated diffuse large B-cell lymphoma, successful management with chemotherapy dose reduction guided by cardiac imaging: A case report and review of literature.

Authors:  Rabah Al-Mehisen; Maha Al-Mohaissen; Hisham Yousef
Journal:  World J Clin Cases       Date:  2019-01-26       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.